Umstead John W. V

Chief Financial Officer at G1 Therapeutics, Inc.

Sold, on record
$62k
Dollars the filings state
Form 4 sales
4
Latest Jul 5, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale G1 Therapeutics, Inc.No plan
    Jan 4, 2024 2024

    Sold 743 shares at $3.09 ($2k)

    Umstead John W. V, Chief Financial Officer

    No 10b5-1 planSold 0.6% of holdings ($406k position)130,443 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale G1 Therapeutics, Inc.No plan
    Mar 18, 2024 +74 days

    Sold 6,547 shares at $3.02 ($20k)

    Umstead John W. V, Chief Financial Officer

    No 10b5-1 planSold 5% of holdings ($394k position)123,896 shares leftFiling

  3. 3 Form 4 sale G1 Therapeutics, Inc.No plan
    May 13, 2024 +56 days

    Sold 8,151 shares at $4.79 ($39k)

    Umstead John W. V, Chief Financial Officer

    No 10b5-1 planSold 5.1% of holdings ($773k position)153,245 shares leftFiling

  4. 4 Form 4 sale G1 Therapeutics, Inc.No plan
    Jul 5, 2024 +53 days

    Sold 527 shares at $2.51 ($1k)

    Umstead John W. V, Chief Financial Officer

    No 10b5-1 planSold 0.3% of holdings ($472k position)187,718 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Umstead John W. V
Source
Jul 5, 2024Jul 8, 2024G1 Therapeutics, Inc.Chief Financial OfficerForm 4 sale527$1k0.3%No planSEC
May 13, 2024May 15, 2024G1 Therapeutics, Inc.Chief Financial OfficerForm 4 sale8,151$39k5.1%No planSEC
Mar 18, 2024Mar 20, 2024G1 Therapeutics, Inc.Chief Financial OfficerForm 4 sale6,547$20k5.0%No planSEC
Jan 4, 2024Jan 8, 2024G1 Therapeutics, Inc.Chief Financial OfficerForm 4 sale743$2k0.6%No planSEC